MARKET

BEAT

BEAT

Heartbeam Inc
NASDAQ
2.050
+0.010
+0.49%
After Hours: 2.050 0 0.00% 18:24 04/24 EDT
OPEN
2.070
PREV CLOSE
2.040
HIGH
2.070
LOW
2.000
VOLUME
13.86K
TURNOVER
0
52 WEEK HIGH
3.740
52 WEEK LOW
1.060
MARKET CAP
53.97M
P/E (TTM)
-2.8472
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BEAT last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at BEAT last week (0408-0412)?
Weekly Report · 04/15 10:56
HeartBeam Presents Results On AI Capabilities For Detecting Arrhythmias
Benzinga · 04/09 13:42
HeartBeam reports positive results of its AI capabilities for detecting arrhythmias
HeartBeam, Inc. Reports positive results of its AI capabilities for detecting arrhythmias. HeartBeam AI with VCG demonstrated a 28% improvement over single-lead ECG in the detection of atrial flutter cases. The company's AI is called StockAI.
Seeking Alpha · 04/09 13:35
HEARTBEAM PRESENTS POSITIVE RESULTS ON ITS ARTIFICIAL INTELLIGENCE CAPABILITIES FOR DETECTING ARRHYTHMIAS
Reuters · 04/09 12:31
Weekly Report: what happened at BEAT last week (0401-0405)?
Weekly Report · 04/08 11:01
Weekly Report: what happened at BEAT last week (0325-0329)?
Weekly Report · 04/01 10:59
Weekly Report: what happened at BEAT last week (0318-0322)?
Weekly Report · 03/25 11:01
More
About BEAT
HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.

Webull offers Heartbeam Inc stock information, including NASDAQ: BEAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BEAT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BEAT stock methods without spending real money on the virtual paper trading platform.